FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
MICROBIOLOGY
PAPER-IV
MICRO/J/20/18/IV
Max. Marks:100
Important Instructions:
Attempt al questions in order.
Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer al the parts of a single question together.
Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Describe the infection control measures in the prevention of COVID-19. What
6+4
centres?
2. Discuss bundle care approach to prevent device associated infections in
10
healthcare settings.
10
4. Define probiotics. Describe their role in the management of bacterial
2+8
infections.
10
6. Describe the requirements to set up a biosafety level 3 laboratory. Draw the
5+5
airflow in Class II A2 biosafety cabinet.
10
microbiology.
8. Role of antibody avidity assay in infectious disease diagnosis. Explain with
6+4
9. Role of Nanotechnology in diagnosis of infectious disease.
10
10. Enumerate Emerging and Re-emerging Viral infections identified as Public
4+6
and possible reasons for emergence.
************
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
MICROBIOLOGY
PAPER-IV
--- Content provided by FirstRanker.com ---
Time: 3 hoursMICRO/J/20/18/IV
Max. Marks:100
Important Instructions:
Attempt al questions in order.
--- Content provided by FirstRanker.com ---
Each question carries 10 marks.Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer al the parts of a single question together.
--- Content provided by FirstRanker.com ---
Start the answer to a question on a fresh page or leave adequate space between two answers.Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Describe the infection control measures in the prevention of COVID-19. What
6+4
--- Content provided by FirstRanker.com ---
are the revision in the biomedical waste management related to Covid- carecentres?
2. Discuss bundle care approach to prevent device associated infections in
10
healthcare settings.
--- Content provided by FirstRanker.com ---
3. With suitable examples, discuss the role of point of care (POC) testing.10
4. Define probiotics. Describe their role in the management of bacterial
2+8
infections.
--- Content provided by FirstRanker.com ---
5. Role of beta D glucan assay in the diagnosis of invasive fungal infections.10
6. Describe the requirements to set up a biosafety level 3 laboratory. Draw the
5+5
airflow in Class II A2 biosafety cabinet.
--- Content provided by FirstRanker.com ---
7. Future prospective and current application of proteomics in clinical10
microbiology.
8. Role of antibody avidity assay in infectious disease diagnosis. Explain with
6+4
--- Content provided by FirstRanker.com ---
an example.9. Role of Nanotechnology in diagnosis of infectious disease.
10
10. Enumerate Emerging and Re-emerging Viral infections identified as Public
4+6
--- Content provided by FirstRanker.com ---
Health threats in India. Discuss current scenario of emerging Viral infectionsand possible reasons for emergence.
************
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
--- Content provided by FirstRanker.com ---